Eldelumab (Anti-CXCL10 / IP-10)

Ask supplier a question | View on supplier's website

Eldelumab (Anti-CXCL10 / IP-10) is a humanised monoclonal antibody (IgG1 type) targeting CXCL10. Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2525
Sku #	A2525-1mg
Pricing	1mg, $670.00

Feedback